Treclin® Gel is supplied by our clinic exclusively for the treatment of diagnosed acne vulgaris, specifically when comedones, papules, and pustules are present. If you have any other medical conditions, please consult your GP for an assessment and a prescription. If you already have a prescription, you can send it to us for dispensing.

Treclin® Gel combines clindamycin, an antibiotic that targets acne-causing bacteria, with tretinoin, which helps to unclog pores and prevent the formation of new comedones. This treatment is effective in reducing acne symptoms and promoting clearer skin.

Why Choose Our PGD Service for Treclin®?
Our PGD service allows for the direct supply of Treclin® Gel to eligible patients without the need for a traditional prescription. This service is guided by strict protocols to ensure patient safety and treatment efficacy.

Who Can Benefit?
Treclin® is recommended for individuals aged 12 to 65 with diagnosed acne vulgaris, where comedones, papules, and pustules are present, and who prefer to access the treatment privately from our clinic without consulting their GP.

Getting Started:
To access Treclin® through our PGD service, start by completing our online consultation. Our team of healthcare professionals will review your information to determine if Treclin® is the right choice for you.

What are the Service Inclusion Criteria?
Treclin® is suitable for a specific group of individuals who meet the following criteria:

• Age Range: 12 to 65 years old.
• Acne Diagnosis: Individuals diagnosed with acne vulgaris presenting comedones, papules, and pustules.
• No Complicating Factors: Suitable for those without complicating skin conditions or history of skin cancer.

What Will Happen Once I Have Answered the Questions in the Form?
A pharmacist trained to provide this private service will assess your form and may contact you to discuss the answers you provided.

Please Note:

• Access to your medical records or consent to contact your GP may be needed.
• As this is a treatment-specific product, we may need to identify you with an identity check (only for first-time buyers).
• Paying for this product will not guarantee its supply as the decision belongs to the pharmacist who will assess your eligibility based on your answers. All denied orders are refunded immediately.

Patient Information Leaflet.

• Active Ingredients:
  • Clindamycin phosphate (1% w/w)
  • Tretinoin (0.025% w/w)
• Excipients:
  • Purified water
  • Glycerol
  • Carbomers
  • Methyl parahydroxybenzoate (E218)
  • Propyl parahydroxybenzoate (E216)
  • Polysorbate 80
  • Disodium edetate
  • Citric acid, anhydrous
  • Butylhydroxytoluene (E321)
  • Trometamol

Treclin® Gel should be applied once daily at night, to clean and dry skin. A small pea-sized amount should be applied to the entire face, avoiding sensitive areas such as the eyes, lips, and nostrils. The gel should be gently rubbed into the skin until it is absorbed. It is important to wash hands thoroughly after application. Treclin® Gel is intended for a maximum treatment period of 12 weeks, after which treatment should be reassessed. If therapeutic improvement is not observed within this period, consult a doctor.

• Treclin® increases susceptibility to UV radiation; minimize sun exposure and avoid sunbeds during treatment.
  • Use a high SPF sunscreen (≥30) and protective clothing when outdoors.
  • If significant irritation or allergic reaction occurs, discontinue use and consult a healthcare professional.
  • Patients with hepatic or renal impairment should use Treclin® with caution due to the potential for increased systemic absorption.

Contraindications

• Hypersensitivity to clindamycin, tretinoin, lincomycin, or any of the excipients listed.
  • Not suitable for use in patients under 12 or over 65 years of age.
  • Do not use if pregnant, breastfeeding, or planning to become pregnant.
  • Avoid in patients with a history of regional enteritis (Crohn's Disease), ulcerative colitis, or antibiotic-associated colitis.
  • Not recommended for patients with acute eczemas, rosacea, perioral dermatitis, or those with a history of skin cancer.
  • Do not apply to sunburned skin or areas that have recently undergone dermatological procedures such as chemical peels or laser resurfacing.
  • Avoid concurrent use with other topical acne treatments or products containing keratolytic agents.

• Common Side Effects:
  • Skin irritation, including redness, dryness, and peeling
  • Burning sensation at the application site
  • Photosensitivity (increased sensitivity to sunlight)
• Uncommon Side Effects:
  • Application site dermatitis
  • Application site discoloration
  • Exacerbation of acne
• Rare Side Effects:
  • Hypersensitivity reactions
  • Gastrointestinal disturbances (nausea, abdominal pain)
  • Headaches

If you experience severe side effects or if symptoms persist, discontinue use and consult your GP or a healthcare professional. Report any adverse effects via the MHRA Yellow Card scheme.

For more information, please refer to the Patient Information Leaflet.